FilmArray drove business growth in molecular biology, contributing €80 million to Q4 revenues and €249 million to FY 2016 revenues.
The company also announced a 5 percent increase in preliminary fourth quarter revenues, to $619 million and above analysts' estimates.
The firm expects full-year revenue growth of up to 39 percent, but fell short of prior guidance for the year.
The firm also reported that full-year 2016 revenues grew 25 percent over 2015, driven in part by strong ePlex instrument sales.
The firm reported preliminary declining revenues for both the fourth quarter and full-year 2016 reporting periods.
The infectious disease diagnostics firm secured eight new contracts covering 18 hospital in the US and Europe during the fourth quarter.
The firm also reported that 2016 preliminary revenues were up 14 percent, and that Nanosphere MDx platform revenues rose 32 percent.
Biopharma revenue grew from $14.1 million to $19 million in the quarter while clinical testing revenue declined from $12 million to $9.8 million.
The company attributed the drop to declines in sales of its urologic and solid tumor testing services as it focused on its new thyroid nodule assay.
The lawsuit, filed last week against Illumina, CEO Francis deSouza, and CFO Marc Stapley, claims that defendants made materially false and misleading statements between July 26 and Oct. 10.
In Science this week: metagenomic-based technique for determining protein structure, and more.
An academic laments the rise of narcissism in the sciences, the Guardian reports.
Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.
The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.